Drug Profile


Alternative Names: Dapoxetine hydrochloride; LY-210448; Priligy

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Eli Lilly
  • Developer Eli Lilly; Furiex Pharmaceuticals; Janssen-Cilag; Menarini
  • Class Antidepressants; Benzylamines; Naphthalenes; Small molecules
  • Mechanism of Action Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Premature ejaculation
  • Discontinued Major depressive disorder

Most Recent Events

  • 31 Dec 2013 Launched for Premature ejaculation in China (PO)
  • 31 Oct 2013 Launched for Premature ejaculation in United Kingdom (PO)
  • 30 Jul 2012 Furiex Pharmaceutics receives worldwide product rights from ALZA Corporation and completes licensing agreement with Menarini
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top